Exoderil External solution, 1%, 20 ml

Exoderil solution for narcotics

approx.

1% fl.

20ml No. 1

Name ENG

EXODERIL

Clinical and pharmacological group

Antifungal drug for external use

ATX code

Naftifine

Dosage

1% x 20ml

Structure

1 ml of solution contains: active substance: naftifine hydrochloride - 10 mg

excipients: propylene glycol - 50 mg, ethanol - 400 mg, purified water - 475 mg.

Storage conditions and periods

At a temperature not higher than 30 degrees.

Expiration date: 5 years

after opening - 6 months

INN / Active ingredient

Naftifin

Specifications

Category

Antifungal

Scope of the drug

Leather

,

Dermatology

Release form

Solution

Manufacturer country

Austria

Package quantity, pcs

one

Scope of application

Dermatology

Way of introduction

Locally

,

Outwardly

Vacation conditions

Without recipe

Volume, ml.

20 ml

Brand name

Sandoz

The amount of the dosage form in the primary package

20 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antifungal agent

Anatomical and therapeutic characteristics

D01AE22 Naftifine

Dosage form

Solution for external use

Packaging

Box

The target audience

Adult

Dosage (volume) of the substance in the preparation

1 ml: naftifine hydrochloride 10 mg

Expiration date in days

1826

Package weight, g

fifty

Mode of application

:

Outwardly.

Exoderil is applied once a day to the affected skin surface and adjacent areas (approximately 1 cm of healthy skin along the edges of the affected area) after thorough cleaning and drying.

The duration of therapy for dermatomycosis is 2-4 weeks (if necessary - up to 8 weeks), with candidiasis - 4 weeks.

In case of nail damage, Exoderil is applied 2 times a day to the affected nail.

Before the first use of the drug, the affected part of the nail is removed as much as possible with scissors or a nail file.

The duration of therapy for onychomycosis is up to 6 months.

To prevent relapse, treatment should be continued for at least 2 weeks after the disappearance of clinical symptoms.